Poniard Pharmaceuticals (PARD) surges in late day action
Poniard Pharmaceuticals, Inc. (Nasdaq: PARD) surges in late day action. Stock up 25% on heavy volume.
Poniard Pharmaceuticals, Inc., together with its subsidiary, NeoRx Manufacturing Group, Inc., focuses on the development and commercialization of oncology products for people with cancer.
Poniard Pharmaceuticals, Inc., together with its subsidiary, NeoRx Manufacturing Group, Inc., focuses on the development and commercialization of oncology products for people with cancer.
You May Also Be Interested In
- OmniVision (OVTI) Volatility Up on Move Lower
- DryShips (DRYS) Trading Higher on Volatility, New Analyst Coverage
- Focus Media Holding (FMCN) Hit on Negative Chanos Mention
Create E-mail Alert Related Categories
Momentum MoversSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
